Institute for Health Policy Forum

Telehealth After the Pandemic: Perils, Promise, and Possibility

June 14, 2021

Telehealth gives us a glimpse into our health care future – but public and private sector choices will determine whether telehealth fully lives up to its promise. Ensuring high-quality, accessible, equitable telehealth will require close attention to several questions:

  • Who is using telehealth, who isn’t, and why?
  • How can leaders promote safe, high-quality telehealth access that enhances coordinated care, advances racial equity, and meets patient needs?
  • How can health care providers design and implement telehealth in a thoughtful way to achieve these goals?

Join us for a conversation about telehealth and the future of care delivery on June 14, 2021 from 10:30 a.m. – 11:45 a.m. PT / 1:30 p.m. – 2:45 p.m. ET.

10:30 a.m. - 10:40 a.m.Opening remarks
10:40 a.m. - 10:50 a.m.The current state of telehealth
10:50 a.m. - 11:40 a.m.The perils, promise, and possibility of telehealth
- Opening remarks
- Discussion
11:40 a.m. - 11:45 a.m.Closing remarks

Veenu Aulakh, MSPH

Veenu Aulakh, MSPH is a Senior Innovation Fellow at the Center for Care Innovations. Previously, she served as CCI’s president from 2012 to 2020 where she grew the organization’s staff, budget and strategy to focus on strengthening the health of under-invested communities. Veenu helped to build critical partnerships to leverage innovation and technology to transform care.

Before joining CCI, Veenu worked as a senior program officer at the California Health Care Foundation, where she managed investments in solutions and programs to improve access to care, improve health outcomes or significantly lower the cost of care. Previously, Veenu held a number of positions within Kaiser Permanente related to improving quality and increasing patient engagement.

Tad Funahashi, MD
Tad Funahashi MD is the Chief Innovation Officer for Kaiser Permanente Southern California. In this role, he leads a team of physicians, consultants, designers, data scientists, and engineers​ who work together with teams and leaders across Kaiser Permanente ​to envision and build the healthcare delivery system of the future at the Kaiser Permanente Innovations Studio.  Dr. Funahashi and the Innovation Studio take a people-first approach to healthcare to enhance the member experience by improving care across the continuum, leveraging big data to provide personalized and improved quality of care, and exploring emerging opportunities that have transformative potential. He is also a practicing orthopedic physician with Southern California Permanente Medical Group.

Reed Tuckson, MD FACP

Over the course of more than 35 years as a health professional, Dr. Tuckson has had the privilege of engaging in nearly every sector of health and medical care, including serving as the Commissioner of Public Health for the District of Columbia; the Senior Vice President for Programs of the March of Dimes Foundation; the President of the Charles R. Drew University of Medicine and Science; the Senior Vice President for Professional Standards of the AMA; the Executive Vice President and Chief of Medical Affairs for UnitedHealth Group, a Fortune 25 Health and Wellbeing Company; and now as the Managing Partner of Tuckson Health Connections.

Currently, Dr. Tuckson serves on the Board of Directors of three public companies: Cell Therapeutics, Inc., a public corporation concerned with the development of cancer pharmaceuticals; The Henry Schein Company, a solutions company for health care professionals; and Adverum Biotechnologies, a clinical stage gene therapy company. He is also Chairman of the Board for the Alliance for Health Policy; a member of the Boards of AcademyHealth and Howard University; He also serves as an Advisory Board Member at Johns Hopkins Berman Institute of Bioethics and EVERMORE; and a member of the MITRE Health Advisory Committee.

Interested in learning more about the Institute for Health Policy’s upcoming events? Complete the contact form below to receive future communications.